November 27, 2021 13:48 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Urge PM Modi to stop flights from countries hit by new COVID variant': Arvind Kejriwal | RJD chief Lalu Prasad Yadav admitted to Delhi's AIIMS with complaints of fever | 77 fresh COVID cases in Karnataka medical college, facility shut | WHO classifies new COVID strain as 'variant of concern', names it 'Omicron' | Muslims offering namaz in Gurgaon interrupted again, faces 'Jai Shri Ram' chants
Covaxin overall 77.8% effective against COVID-19, claims Bharat Biotech Covaxin
Image tweeted by @IndianEmbassyTR

Covaxin overall 77.8% effective against COVID-19, claims Bharat Biotech

IBNS | @indiablooms | 03 Jul 2021, 01:24 pm

New Delhi/IBNS: Hyderabad-based biotechnology company Bharat Biotech has claimed its anti-COVID-19 vaccine, Covaxin, is 77.8% effective against the deadly virus.

Bharat Biotech made the claim in the phase three clinical trial data of the vaccine.

The company has further claimed Covaxin is 93.4% effective against severe symptomatic COVID-19 cases, 63.6% against asymptomatic COVID-19 cases and 65.2% against the Delta variant.

Bharat Biotech co-founder Suchitra Ella tweeted, "We are proud to put India on the global map with scientific conviction,competence & commitment. #Covaxin scores #10 world class publications endorsing Innovation, clinical research,data,safety, efficacy. Thanq collaborators & Positive BB teamwork enduring a pandemic."

At present four anti-COVID-19 vaccines including Covaxin have been permitted by the central government to be used in the vaccination drive.

Apart from Covaxin, three other vaccines are AstraZeneca's Indian version Covishield, Russia's Sputnik and US-made Moderna.